GNMK - they are continuing to move today in a low resistance price area. They pre-reported expected 80% increase in revenue based on their COVID test. They report after market on May 4.
BCRX - I'd like to see it clear a resistance line today and retake Monday's highs. They are working on a COVID vaccine and will report on May 6 pre-market.
NVAX - they reported back in March, so this isn't an earnings play. Just as a reminder, in March they reported very good Phase III results on their NanoFlu vaccine. Next step is market approval from FDA. They got taken down on Tuesday on a short-sellers news release raising all sorts of "ghosts" from NVAX's past - i.e., no vaccines and the threat of more dilution. That dilution concern gave me pause because I remember that in the past. I think it's much different now, however. They HAVE a vaccine that showed good efficacy over the competition. That's money in the bank for them. They also have an agreement with another firm to produce the vaccine, so they don't need the big cash infusion to bring it to market. Personally, I just want a buy-out so I can just let this go, lol!
| 
